Boston Scientific Pre-Tax Income 2010-2024 | BSX

Boston Scientific annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Boston Scientific pre-tax income for the quarter ending September 30, 2024 was $0.669B, a 9.67% increase year-over-year.
  • Boston Scientific pre-tax income for the twelve months ending September 30, 2024 was $2.202B, a 17.44% increase year-over-year.
  • Boston Scientific annual pre-tax income for 2023 was $1.985B, a 73.97% increase from 2022.
  • Boston Scientific annual pre-tax income for 2022 was $1.141B, a 6.04% increase from 2021.
  • Boston Scientific annual pre-tax income for 2021 was $1.076B, a 1462.03% decline from 2020.
Boston Scientific Annual Pre-Tax Income
(Millions of US $)
2023 $1,985
2022 $1,141
2021 $1,076
2020 $-79
2019 $687
2018 $1,422
2017 $933
2016 $177
2015 $-650
2014 $-509
2013 $-223
2012 $-4,107
2011 $642
2010 $-1,063
2009 $-1,308
Boston Scientific Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $669
2024-06-30 $420
2024-03-31 $608
2023-12-31 $505
2023-09-30 $610
2023-06-30 $426
2023-03-31 $444
2022-12-31 $395
2022-09-30 $245
2022-06-30 $345
2022-03-31 $156
2021-12-31 $119
2021-09-30 $483
2021-06-30 $149
2021-03-31 $325
2020-12-31 $307
2020-09-30 $-227
2020-06-30 $-181
2020-03-31 $22
2019-12-31 $-6
2019-09-30 $91
2019-06-30 $145
2019-03-31 $457
2018-12-31 $296
2018-09-30 $456
2018-06-30 $347
2018-03-31 $323
2017-12-31 $228
2017-09-30 $309
2017-06-30 $91
2017-03-31 $305
2016-12-31 $89
2016-09-30 $257
2016-06-30 $-397
2016-03-31 $228
2015-12-31 $-337
2015-09-30 $-367
2015-06-30 $105
2015-03-31 $-51
2014-12-31 $-554
2014-09-30 $3
2014-06-30 $-104
2014-03-31 $146
2013-12-31 $59
2013-09-30 $-40
2013-06-30 $152
2013-03-31 $-394
2012-12-31 $51
2012-09-30 $-663
2012-06-30 $-3,618
2012-03-31 $123
2011-12-31 $100
2011-09-30 $111
2011-06-30 $158
2011-03-31 $273
2010-12-31 $230
2010-09-30 $163
2010-06-30 $119
2010-03-31 $-1,575
2009-12-31 $-1,347
2009-09-30 $-44
2009-06-30 $180
2009-03-31 $-97
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $130.065B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.220B 25.79
Stryker (SYK) United States $143.322B 32.30
Medtronic (MDT) Ireland $112.498B 16.74
EssilorLuxottica (ESLOY) France $111.686B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.423B 0.00
Haleon (HLN) United Kingdom $43.501B 28.26
GE HealthCare Technologies (GEHC) United States $39.264B 20.36
ResMed (RMD) United States $37.048B 30.44
Terumo (TRUMY) Japan $29.575B 41.77
Koninklijke Philips (PHG) Netherlands $25.012B 19.14
Zimmer Biomet Holdings (ZBH) United States $21.536B 13.71
Insulet (PODD) United States $18.791B 74.86
Baxter (BAX) United States $17.673B 11.51
Smith & Nephew SNATS (SNN) United Kingdom $10.619B 0.00
Bio-Rad Laboratories (BIO) United States $10.338B 35.13
BellRing Brands (BRBR) United States $9.136B 38.63
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $6.084B 14.14
Haemonetics (HAE) United States $4.474B 21.43
TG Therapeutics (TGTX) United States $4.460B 0.00
ICU Medical (ICUI) United States $4.318B 41.21
Prestige Consumer Healthcare (PBH) United States $3.983B 19.75
Perrigo (PRGO) Ireland $3.596B 10.59
Neogen (NEOG) United States $3.517B 40.57
Envista Holdings (NVST) United States $3.509B 26.14
Agios Pharmaceuticals (AGIO) United States $3.368B 0.00
GN Store Nord (GNNDY) Denmark $3.041B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.942B 18.94
LeMaitre Vascular (LMAT) United States $2.342B 56.97
Warby Parker (WRBY) United States $1.964B 0.00
Green Thumb Industries (GTBIF) United States $1.888B 33.04
AtriCure (ATRC) United States $1.826B 0.00
InMode (INMD) Israel $1.630B 9.80
Curaleaf Holdings (CURLF) Canada $1.384B 0.00
AdaptHealth (AHCO) United States $1.357B 9.70
Maravai LifeSciences Holdings (MRVI) United States $1.280B 0.00
BioLife Solutions (BLFS) United States $1.206B 0.00
Owens & Minor (OMI) United States $0.995B 7.77
Phibro Animal Health (PAHC) United States $0.966B 17.04
CeriBell (CBLL) United States $0.962B 0.00
National Vision Holdings (EYE) United States $0.906B 30.29
Capricor Therapeutics (CAPR) United States $0.895B 0.00
Evolus (EOLS) United States $0.866B 0.00
Verano Holdings (VRNOF) United States $0.691B 0.00
Cresco Labs (CRLBF) United States $0.605B 0.00
VAREX IMAGING (VREX) United States $0.582B 17.56
Quanterix (QTRX) United States $0.580B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Valneva SE (VALN) France $0.426B 0.00
Canopy Growth (CGC) Canada $0.398B 0.00
ZimVie (ZIMV) United States $0.393B 33.12
Viemed Healthcare (VMD) United States $0.353B 33.59
Cerus (CERS) United States $0.331B 0.00
OraSure Technologies (OSUR) United States $0.320B 21.45
Sanara MedTech (SMTI) United States $0.308B 0.00
Biote (BTMD) United States $0.301B 13.90
Zynex (ZYXI) United States $0.287B 60.07
Jin Medical (ZJYL) China $0.284B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
TerrAscend (TSNDF) Canada $0.269B 0.00
Aurora Cannabis (ACB) Canada $0.264B 0.00
Omeros (OMER) United States $0.256B 0.00
Utah Medical Products (UTMD) United States $0.236B 15.90
High Tide (HITI) Canada $0.221B 91.67
Brainsway (BWAY) Israel $0.181B 217.20
Organigram Holdings (OGI) Canada $0.172B 0.00
FitLife Brands (FTLF) United States $0.151B 20.39
Rockwell Medical (RMTI) United States $0.137B 0.00
TriSalus Life Sciences (TLSI) United States $0.129B 0.00
Quipt Home Medical (QIPT) United States $0.116B 0.00
Zevia PBC (ZVIA) United States $0.111B 0.00
Veru (VERU) United States $0.107B 0.00
Ayr Wellness (AYRWF) United States $0.104B 0.00
Fonar (FONR) United States $0.095B 9.82
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.10
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.67
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
MariMed (MRMD) United States $0.062B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Exagen (XGN) United States $0.050B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
Nephros (NEPH) United States $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.20
SNDL (SNDL) Canada $0.000B 0.00